Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ) closed at $2.47 on November 2, 2026, up 1.23% on the day. The stock trades 54.7% below its 52-week high of $5.45 and 14.1% above its 52-week low of $2.17. Over the past year, it lost 30.6%. Rocket Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 31, 2025, RCKT closed higher on 116 days (46%). Its best day was March 9, 2026 (+15.87%) and its worst was March 27, 2026 (-19.62%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.
Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.
Find more stocks like RCKT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.